USANA Health Sciences, Inc. (NYSE:USNA) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, June 13th.
Other equities analysts have also recently issued research reports about the company. Pivotal Research raised USANA Health Sciences from a “hold” rating to a “buy” rating and upped their price target for the stock from $55.00 to $75.00 in a report on Wednesday, May 3rd. Zacks Investment Research raised USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Wednesday, April 12th.
USANA Health Sciences (NYSE:USNA) traded down 1.92% during midday trading on Tuesday, hitting $63.75. 49,090 shares of the stock were exchanged. USANA Health Sciences has a 1-year low of $52.55 and a 1-year high of $75.00. The company’s 50 day moving average is $63.85 and its 200 day moving average is $60.63. The company has a market capitalization of $1.56 billion, a P/E ratio of 16.09 and a beta of 1.10.
USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, May 2nd. The company reported $0.91 earnings per share for the quarter, missing analysts’ consensus estimates of $0.92 by $0.01. The business had revenue of $255.32 million during the quarter. USANA Health Sciences had a return on equity of 25.23% and a net margin of 8.37%. Analysts predict that USANA Health Sciences will post $3.95 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “USANA Health Sciences, Inc. (USNA) Stock Rating Upgraded by BidaskClub” was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://sportsperspectives.com/2017/06/20/usana-health-sciences-inc-usna-stock-rating-upgraded-by-bidaskclub-updated.html.
In related news, insider Paul A. Jones sold 9,851 shares of the stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $64.50, for a total value of $635,389.50. Following the completion of the sale, the insider now owns 6,020 shares of the company’s stock, valued at $388,290. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Myron W. Wentz sold 40,000 shares of the stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $56.39, for a total value of $2,255,600.00. The disclosure for this sale can be found here. Insiders have sold 174,735 shares of company stock valued at $10,349,724 in the last three months. Insiders own 53.20% of the company’s stock.
Several large investors have recently bought and sold shares of USNA. Goldman Sachs Group Inc. boosted its stake in USANA Health Sciences by 107.2% in the first quarter. Goldman Sachs Group Inc. now owns 56,373 shares of the company’s stock valued at $3,247,000 after buying an additional 29,162 shares in the last quarter. Tudor Investment Corp ET AL boosted its stake in USANA Health Sciences by 33.6% in the first quarter. Tudor Investment Corp ET AL now owns 14,818 shares of the company’s stock valued at $854,000 after buying an additional 3,727 shares in the last quarter. Highbridge Capital Management LLC bought a new stake in USANA Health Sciences during the first quarter valued at approximately $254,000. Schwab Charles Investment Management Inc. boosted its stake in USANA Health Sciences by 3.6% in the first quarter. Schwab Charles Investment Management Inc. now owns 124,961 shares of the company’s stock valued at $7,198,000 after buying an additional 4,297 shares in the last quarter. Finally, Lucus Advisors LLC bought a new stake in USANA Health Sciences during the first quarter valued at approximately $284,000. 44.26% of the stock is owned by hedge funds and other institutional investors.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.